Zobrazeno 1 - 10
of 78
pro vyhledávání: '"H M Prince"'
Autor:
H. Quach, G. Parmar, E. M. Ocio, H. M. Prince, A. Oriol, N. Tsukada, K. Sunami, P. Bories, C. Karanes, S. Madan, D. Semiond, M. Inchauspe, S. Macé, P. B. Musholt, F. Suzan, P. Moreau
Publikováno v:
HemaSphere, Vol 6, Pp 835-836 (2022)
Externí odkaz:
https://doaj.org/article/794b1fbec02a49cc83120a7013a24c8d
Autor:
N. S. N. Shaharum, H. Z. M. Shafri, W. A. W. A. K. Ghani, S. Samsatli, B. Yusuf, M. M. A. Al-Habshi, H. M. Prince
Publikováno v:
The International Archives of the Photogrammetry, Remote Sensing and Spatial Information Sciences, Vol XLII-4-W9, Pp 133-137 (2018)
The world has been alarmed with the global warming effects. Global warming has been a distress towards the environment, thus shorten the Earth’s lifespan. It is a challenging task to reduce the global warming effects in a short period, knowing that
Externí odkaz:
https://doaj.org/article/046c2ae78f6043d69840b480d608fa6c
Autor:
Yoon-Kyoung Sung, Kazuki Yoshida, Femke H M Prince, Michelle L Frits, Soo-Kyung Cho, Jung-Yoon Choe, Hye-Soon Lee, Jisoo Lee, Shin-Seok Lee, Dae-Hyun Yoo, Simon M Helfgott, Nancy A Shadick, Michael E Weinblatt, Daniel H Solomon, Sang-Cheol Bae
Publikováno v:
PLoS ONE, Vol 14, Iss 8, p e0221314 (2019)
[This corrects the article DOI: 10.1371/journal.pone.0214981.].
Externí odkaz:
https://doaj.org/article/9da59b6ad3054a62ba92d22064f7d001
Autor:
Juliana Pereira, Astrid Pavlovsky, Eliza A Hawkes, A. Lymboussakis, I. Kryachok, Lorena Fiad, R. Nair, Carla Minoia, C.A. De Souza, C.S. Chiattone, R. Advani, Stefano Luminari, H. M. Prince, Massimo Federico, Martina Manni, Tetiana Skrypets, C. Tomuleasa, N. S. De Castro, P. Pereyra, Monica Civallero
Publikováno v:
Hematological Oncology. 39
Introduction: Mature T and NK-cell lymphomas represent a heterogeneous group of lymphoid disorders (29 subtypes according to the 2016 WHO classification) arising from mature T cells of post-thymic origin with different morphological characteristics,
Autor:
Faekah Gohar, Marion A J van Rossum, Janneke Anink, Gerd Horneff, Dirk Holzinger, Koert M. Dolman, Esther P A H Hoppenreijs, Michael Frosch, Lisette W A van Suijlekom-Smit, Simona Ursu, Lucy R. Wedderburn, Rebecca ten Cate, Halima Moncrieffe, Dirk Foell, Femke H M Prince
Publikováno v:
The Journal of Rheumatology, 45, 547-554
Journal of Rheumatology, 45(4), 547-554. Journal of Rheumatology
Journal of Rheumatology, 45(4), 547-554
Journal of rheumatology, 45(4), 547-554. Journal of Rheumatology
Journal of Rheumatology
The Journal of Rheumatology, 45, 4, pp. 547-554
Journal of Rheumatology, 45(4), 547-554. Journal of Rheumatology
Journal of Rheumatology, 45(4), 547-554
Journal of rheumatology, 45(4), 547-554. Journal of Rheumatology
Journal of Rheumatology
The Journal of Rheumatology, 45, 4, pp. 547-554
Objective.Around one-third of patients with juvenile idiopathic arthritis (JIA) fail to respond to first-line methotrexate (MTX) or anti-tumor necrosis factor (TNF) therapy, with even fewer achieving ≥ American College of Rheumatology Pediatric 70%
Autor:
Michelle L. Frits, Soo-Kyung Cho, Yoon Kyoung Sung, Nancy A. Shadick, Jung Yoon Choe, Hye Soon Lee, Michael E. Weinblatt, Jisoo Lee, Dae Hyun Yoo, Sang Cheol Bae, Daniel H. Solomon, Kazuki Yoshida, Femke H M Prince, Shin-Seok Lee, Simon M. Helfgott
Publikováno v:
PLoS ONE, Vol 14, Iss 8, p e0221314 (2019)
[This corrects the article DOI: 10.1371/journal.pone.0214981.].
Publikováno v:
Cancer treatment and research. 176
There are a number of rare T-cell lymphoma subtypes that may be encountered in clinical practice. In recent years, improved immunohistochemical techniques and molecular tumor profiling have permitted refinement of some of the diagnostic categories in
Autor:
Anna K. Dorai Raj, Femke H M Prince, Johannes C. van der Wouden, Kathleen Tymms, Lisette W A van Suijlekom-Smit, Peter P. M. Cheung, Marieke H Otten
Publikováno v:
Cochrane Database of Systematic Reviews, 2018(8):Cd008598. John Wiley & Sons Ltd.
Cochrane Database Systematics Review, 7, 1-10. John Wiley & Sons Ltd.
Cochrane Database of Systematic Reviews, 2018(8):CD008598. John Wiley and Sons Ltd
Prince, F H M, Dorai Raj, A K, Otten, M H, Cheung, P P M, Tymms, K E, van Suijlekom-Smit, L W A & van der Wouden, J C 2018, ' TNF-alpha inhibitors for juvenile idiopathic arthritis ', Cochrane Database of Systematic Reviews, vol. 2018, no. 8, CD008598 . https://doi.org/10.1002/14651858.CD008598.pub2
Cochrane database of systematic reviews (Online), 2018(8):CD008598. John Wiley and Sons Ltd
The Cochrane Library
Cochrane Database Systematics Review, 7, 1-10. John Wiley & Sons Ltd.
Cochrane Database of Systematic Reviews, 2018(8):CD008598. John Wiley and Sons Ltd
Prince, F H M, Dorai Raj, A K, Otten, M H, Cheung, P P M, Tymms, K E, van Suijlekom-Smit, L W A & van der Wouden, J C 2018, ' TNF-alpha inhibitors for juvenile idiopathic arthritis ', Cochrane Database of Systematic Reviews, vol. 2018, no. 8, CD008598 . https://doi.org/10.1002/14651858.CD008598.pub2
Cochrane database of systematic reviews (Online), 2018(8):CD008598. John Wiley and Sons Ltd
The Cochrane Library
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: The aim of this review is to assess the benefit and safety of TNF-α inhibitors in JIA.
Autor:
Jung Yoon Choe, Nancy A. Shadick, Shin-Seok Lee, Michael E. Weinblatt, Kazuki Yoshida, Michelle L. Frits, Soo Kyung Cho, Yoon Kyoung Sung, Femke H M Prince, Simon M. Helfgott, Daniel H. Solomon, Jisoo Lee, Dae Hyun Yoo, Sang Cheol Bae, Hye Soon Lee
Publikováno v:
PLoS ONE, Vol 14, Iss 4, p e0214981 (2019)
PLoS One (online), 14(4):e0214981. Public Library of Science
PLoS ONE
PLoS One (online), 14(4):e0214981. Public Library of Science
PLoS ONE
textabstractObjective Remission is a key goal in managing rheumatoid arthritis (RA), with sustained remission as the preferred sequelae of short-term remission. However little is known about the predictors of sustained remission for patients reaching
Publikováno v:
Pediatric Drugs. 15:271-280
Biologics are a promising treatment option for juvenile idiopathic arthritis (JIA) but drug costs are very high compared to conventional treatment. From a socioeconomic view the additional costs of new interventions should be weighed against their in